Loading...

FITC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_FITC_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
  • N418_A_FITC_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
  • N418_B_FITC_Neg_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
117305 50 µg 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117306 500 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  3. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  4. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  5. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  6. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  7. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  8. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  9. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  10. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  11. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  12. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  13. Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed
  14. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  15. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  16. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  17. Li X, et al. 2022. Cell. 185:1709. PubMed
  18. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  19. Li Q, et al. 2022. Biomed Pharmacother. 153:113459. PubMed
  20. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  21. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  22. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  23. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  24. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  25. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  26. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  27. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  28. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  29. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  30. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  31. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  32. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  33. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  34. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  35. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  36. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  37. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  38. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  39. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  40. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  41. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  42. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  43. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  44. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  45. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  46. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  47. Zhu H, et al. 2018. Elife. 7:. PubMed
  48. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  49. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  50. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  51. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  52. Devenport SN, et al. 2021. JCI Insight. 6: . PubMed
  53. Pott J et al. 2018. Cell host & microbe. 23(2):191-202 . PubMed
  54. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  55. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  56. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  57. Xing J, et al. 2016. Nat Immunol. 17:1373-1380. PubMed
  58. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  59. Schwartz AJ, et al. 2021. Nat Metab. 3:969. PubMed
  60. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  61. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  62. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  63. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  64. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  65. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  66. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  67. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  68. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  69. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  70. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  71. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  72. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  73. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  74. Mizraji* G, et al. 2013. J Vis Exp. 77: 50388. PubMed
  75. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  76. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  77. Shen J, et al. 2022. Mater Today Bio. 16:100416. PubMed
  78. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  79. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  80. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  81. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  82. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  83. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  84. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  85. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  86. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  87. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  88. Coe D, et al. 2022. JCI Insight. 7:. PubMed
  89. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  90. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  91. Wan X, et al. 2018. Nature. 560:107. PubMed
  92. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  93. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  94. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  95. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  96. Bharali D, et al. 2008. Nanomedicine. 4:311. PubMed
  97. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  98. Xue RY, et al. 2019. Front Immunol. 10:1372. PubMed
  99. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  100. Mao L, et al. 2022. Front Immunol. 13:833418. PubMed
  101. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  102. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  103. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  104. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  105. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  106. Kostadinova E, et al. 2016. Sci Rep. 6:30943. PubMed
  107. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  108. Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
  109. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  110. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  111. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  112. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  113. Han W, et al. 2020. J Immunol. 205:1125. PubMed
  114. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  115. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  116. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  117. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  118. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  119. Bi E, et al. 2018. J Clin Invest. 128:4821. PubMed
  120. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  121. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  122. Miki Y, et al. 2022. JCI Insight. 7:. PubMed
  123. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  124. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  125. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  126. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  127. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  128. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  129. Jaiswal M, et al. 2014. J Leukoc Biol. 96:337. PubMed
  130. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  131. Chin R, et al. 2006. J Immunol. 177:290. PubMed
  132. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  133. Qin S, et al. 2018. Oncol Lett. 128:1283. PubMed
  134. Gu H, et al. 2021. Elife. 10:. PubMed
  135. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  136. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  137. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  138. Barrera-Avalos C, et al. 2021. iScience. 24:103520. PubMed
  139. Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
  140. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  141. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  142. Poncini C, et al. 2015. J Immunol. 195: 3311 - 3324. PubMed
  143. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  144. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  145. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  146. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  147. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  148. Wang X, et al. 2022. Elife. 11:. PubMed
  149. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  150. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  151. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  152. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  153. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  154. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  155. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  156. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  157. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  158. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  159. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  160. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  161. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  162. Bidet K, et al. 2019. NPJ Vaccines. 4:27. PubMed
  163. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  164. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  165. Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed
  166. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  167. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  168. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
RRID
AB_313774 (BioLegend Cat. No. 117305)
AB_313775 (BioLegend Cat. No. 117306)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account